Status:
COMPLETED
Staphylococcus Aureus Decolonization Study
Lead Sponsor:
Washington University School of Medicine
Conditions:
Staphylococcal Skin Infections
Abscesses
Eligibility:
All Genders
6-21 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether measures to eliminate the Staph germ from the skin of the index patient (with a special ointment and soap) are more effective when performed by everyo...
Detailed Description
Methicillin-resistant Staphylococcus aureus (MRSA) was once uniformly associated with hospital-acquired infections; however, MRSA strains have emerged that thrive outside the hospital environment, cau...
Eligibility Criteria
Inclusion
- Screening:
- Children aged 6 months to 21 years presenting with an active skin or soft tissue infection.
- Enrollment:
- Positive MRSA culture from the abscess and from either the axilla, anterior nares or groin area (signifying both infection and colonization with MRSA).
Exclusion
- Infants less than 6 months of age
- Dialysis or residence in a long term care facility over the past year
- Use of chlorhexidine or mupirocin in the past one month
- Pregnancy
- Immunodeficiency
- History of an adverse reaction to chlorhexidine or mupirocin.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
183 Patients enrolled
Trial Details
Trial ID
NCT00731783
Start Date
July 1 2008
End Date
December 1 2010
Last Update
April 30 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Louis Children's Hospital
St Louis, Missouri, United States, 63110